Technical Analysis for UBI - Universal Biosensors, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.140 | 7.69% | 0.010 |
Earnings due: May 30
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | 7.69% | |
| Wide Bands | Range Expansion | 7.69% | |
| Oversold Stochastic | Weakness | 7.69% | |
| Narrow Range Bar | Range Contraction | 7.69% | |
| Stochastic Reached Oversold | Weakness | 7.69% |
| Alert | Time |
|---|---|
| Up 5% | about 17 hours ago |
| Rose Above Previous Day's High | about 20 hours ago |
| Up 2% | about 20 hours ago |
| Up 1% | about 20 hours ago |
| Up 3% | about 20 hours ago |
Get a Trading Assistant
Universal Biosensors, Inc. Description
Universal Biosensors, Inc. is a specialist medical diagnostics company. The Company is focused on the research, development and manufacture of in vitro diagnostic test devices for consumer and professional point-of-care use. The Company's subsidiary, Universal Biosensors Pty Ltd, conducts its research, development and manufacturing activities. The Company uses its electrochemical cell technology platform to develop point-of-care testing systems for a range of different markets. The Company is engaged in the development of its own Prothrombin Time International Normalized Ratio (PT-INR) test for use in decentralized settings, including the patient self-test market. It is engaged in demonstrating the various applications of its technology platform, including its application to diagnostic tests based on enzymatic, immunoassay and molecular diagnostic methods. It has developed a blood glucose test with LifeScan, Inc. and a coagulation PT-INR test with Siemens Healthcare Diagnostics Inc.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Health Manufacturing Medicine Healthcare Chemical Biotechnology Life Sciences Mali In Vitro Medical Tests Inr Immunoassay Medical Diagnostic Diagnostic Tests
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.32 |
| 52 Week Low | 0.13 |
| Average Volume | 969,173 |
| 200-Day Moving Average | 0.213 |
| 50-Day Moving Average | 0.169 |
| 20-Day Moving Average | 0.156 |
| 10-Day Moving Average | 0.146 |
| Average True Range | 0.011 |
| RSI (14) | 39.39 |
| ADX | 22.4 |
| +DI | 24.733 |
| -DI | 40.592 |
| Chandelier Exit (Long, 3 ATRs) | 0.171 |
| Chandelier Exit (Short, 3 ATRs) | 0.164 |
| Upper Bollinger Bands | 0.189 |
| Lower Bollinger Band | 0.124 |
| Percent B (%b) | 0.25 |
| BandWidth | 41.203 |
| MACD Line | -0.011 |
| MACD Signal Line | -0.009 |
| MACD Histogram | -0.0022 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.148 | ||||
| Resistance 3 (R3) | 0.147 | 0.143 | 0.146 | ||
| Resistance 2 (R2) | 0.143 | 0.141 | 0.144 | 0.146 | |
| Resistance 1 (R1) | 0.142 | 0.140 | 0.143 | 0.143 | 0.145 |
| Pivot Point | 0.138 | 0.138 | 0.139 | 0.139 | 0.138 |
| Support 1 (S1) | 0.137 | 0.136 | 0.138 | 0.138 | 0.135 |
| Support 2 (S2) | 0.133 | 0.135 | 0.134 | 0.134 | |
| Support 3 (S3) | 0.132 | 0.133 | 0.134 | ||
| Support 4 (S4) | 0.133 |
